To analyze the efficacy and safety of plasma exchange in the treatment of anti‐ NMDA receptor encephalitis
Therapeutic Apheresis and Dialysis · 2026
DOI: 10.1111/1744-9987.14240 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, 2026. Verfasst von Jing Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Wuzhou Red Cross Hospital, Wuzhou, China. Hauptthemen laut MEDLINE: Plasma Exchange, Anti-N-Methyl-D-Aspartate Receptor Encephalitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
To investigate the clinical efficacy and safety of plasma exchange (PE) in the treatment of glucocorticoid‐insensitive patients with serum anti‐ N ‐methyl‐ d ‐aspartate (anti‐NMDA) receptor antibody‐negative and serum anti‐NMDA receptor antibody‐positive encephalitis.
Methods
The clinical data of 20 patients with anti‐NMDA receptor antibody encephalitis treated between January 2015 and December 2022 were collected. The general information, clinical symptoms, auxiliary examination, treatment (hormone, PE, etc.), adverse reactions, clinical efficacy, and other related data were retrospectively compared and analyzed.
Results
A total of 8 cases had adverse reactions (9.76%, 8/82), including 4 cases (4.88%, 4/82) of allergy and 2 cases (2.44%,2/82) of thrombocytopenia. In patients with anti‐NMDA receptor antibody encephalitis who were not sensitive to glucocorticoids, the effective rate of PE was 80.0% ( p = 0.0005).
Conclusion
PE combined with glucocorticoid is more effective than glucocorticoid alone in the treatment of anti‐NMDA receptor antibody encephalitis patients with positive or negative anti‐NMDA receptor antibodies. Most adverse reactions were mild and easy to manage. It does not cause obvious blood cell loss. PE is a safe and acceptable treatment. However, our study has limitations, and due to the small number of people and the fact that plasmapheresis was performed after glucocorticoid therapy, further prospective clinical studies are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Wuzhou Red Cross Hospital, Wuzhou, China.
- General Internal Medicine, Guangxi Medical University Cancer Hospital, Nanning, China.
- Department of Nephrology, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
- Department of Nephrology, Yulin First People's Hospital, Nanning, China.
- Department of Intensive Care Medicine, Guangxi Medical University Cancer Hospital, Nanning, China.
ORCID-Profile: Kaiqing Xie
Zitieren
APA
Li, J., Huang, B., Lao, Q., Zou, L., & Xie, K. (2026). To analyze the efficacy and safety of plasma exchange in the treatment of anti‐ NMDA receptor encephalitis. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14240
Vancouver
Li J, Huang B, Lao Q, Zou L, Xie K. To analyze the efficacy and safety of plasma exchange in the treatment of anti‐ NMDA receptor encephalitis. Therapeutic Apheresis and Dialysis. 2026. doi:10.1111/1744-9987.14240
BibTeX
@article{Li2026,
author = {Li, Jing and Huang, Binghai and Lao, Qifang and Zou, Longtao and Xie, Kaiqing},
title = {To analyze the efficacy and safety of plasma exchange in the treatment of anti‐ NMDA receptor encephalitis},
journal = {Therapeutic Apheresis and Dialysis},
year = {2026},
doi = {10.1111/1744-9987.14240}
}
EUVIMED